High LDL levels are associated with increased lipoprotein-associated phospholipase A(2) activity on nitric oxide synthesis and reactive oxygen species formation in human endothelial cells

dc.contributor.authorSearle, Andrea
dc.contributor.authorGómez Rosso, Leonardo
dc.contributor.authorMeroño, Tomás
dc.contributor.authorSalomon, Carlos
dc.contributor.authorDurán-Sandoval, Daniel
dc.contributor.authorGiunta, Gustavo
dc.contributor.authorGrant, Carlos
dc.contributor.authorCalvo, Carlos
dc.contributor.authorLamperti, Liliana
dc.contributor.authorBrites, Fernando
dc.contributor.authorAguayo, Claudio
dc.date.accessioned2023-02-16T11:01:34Z
dc.date.available2023-02-16T11:01:34Z
dc.date.issued2011-02-05
dc.date.updated2023-02-16T11:01:34Z
dc.description.abstractObjective: To evaluate in vitro the effects of serum and LDL fractions isolated from hypercholesterolemic patients on nitric oxide (NO) synthesis and reactive oxygen species (ROS) production by human umbilical vein endothelial cells (HUVECs). Design and methods: Serum and LDL isolated from subjects with high (n=18) and normal (n=21) LDL-cholesterol levels were analyzed on NO synthesis and ROS production in vitro models of HUVECs. LDL was furthers characterized in their chemical composition and activities of lipoprotein-associated phospholipase A(2) (Lp-PLA(2)), cholesteryl ester transfer protein (CETP) and paraoxonase. Results: NO bioavailability was significantly lower and ROS production higher in HUVECs incubated with serum samples from patients with high LDL-cholesterol levels in comparison to control subjects. Moreover, hypercholesterolemic patients presented higher CETP and Lp-PLA(2) activities than control subjects. LDL fractions isolated from patients and controls were not different in their chemical composition, Lp-PLA(2) activity, and their capacity to reduce NO synthesis and increase ROS production. Conclusion: Alterations of serum from hypercholesterolemic patients could be due to the increment in LDL concentration, main Lp-PLA(2) carrier, and not to LDL composition or intrinsic Lp-PLA(2) activity.
dc.format.extent7 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec728116
dc.identifier.issn0009-9120
dc.identifier.urihttps://hdl.handle.net/2445/193701
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1016/j.clinbiochem.2010.10.004
dc.relation.ispartofClinical Biochemistry, 2011, vol. 44, num. 2, p. 171-177
dc.relation.urihttps://doi.org/10.1016/j.clinbiochem.2010.10.004
dc.rights(c) Elsevier B.V., 2011
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Nutrició, Ciències de l'Alimentació i Gastronomia)
dc.subject.classificationLipoproteïnes
dc.subject.classificationColesterol
dc.subject.classificationMalalties cardiovasculars
dc.subject.otherLipoproteins
dc.subject.otherCholesterol
dc.subject.otherCardiovascular diseases
dc.titleHigh LDL levels are associated with increased lipoprotein-associated phospholipase A(2) activity on nitric oxide synthesis and reactive oxygen species formation in human endothelial cells
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
728116.pdf
Mida:
314.86 KB
Format:
Adobe Portable Document Format